Document is current
Any future updates will be listed below
-
Authors
Wagner, Rachel B.
Wester, James R.
Motladiile, Bosa
Nkele, Isaac
Chinyepi, Nkhabe
Tshisimogo, Gontse
Vuylsteke, Peter
Lockman, Shahin
Dryden-Peterson, Scott
Kohler, Racquel E.
-
Funding
Funding for this research was provided by:
NIH (D43 TW010543)
NIH (K24AI131928)
NIH (P30CA006516-50S4)
NIH (K22CA258675)
- License Information
-
More Information
Article History
Received: 14 October 2024
Accepted: 1 September 2025
First Online: 20 September 2025
Declarations
:
: This protocol was reviewed and approved by the Harvard T.H. Chan School of Public Health Institutional Review Board (Pro#18653) and the Health Research Development Committee of the Botswana Ministry of Health.
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for publication of deidentified data.
: PV has received travel support from Roche and MSD Oncology and honoraria from Roche/Genentech, Novartis, and MSD Oncology. SDP has received royalties from UpToDate, Inc. The remaining authors have no relevant financial or non-financial interests to disclose. Peter Vuylsteke has received travel support from Roche and MSD Oncology and honoraria from Roche/Genentech, Novartis, and MSD Oncology. Scott Dryden-Peterson has received royalties from UpToDate, Inc.
